[Initial Clinical Experiences Using Ocriplasmin for the Treatment of Vitreomacular Traction with or without a Macular Hole].

Conclusion Intravitreal injection of ocriplasmin appears is an experimental therapy in patients with symptomatic vitreomacular traction. Patient selection seems to be critically important for the therapeutic outcome, whereas greater age, specific VMT morphology and missing chromatopsia seem to be negative predictors. PMID: 28282697 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/28282697?dopt=Abstract

Source: Klinische Monatsblatter fur Augenheilkunde - March 11, 2017 Category: Opthalmology Tags: Klin Monbl Augenheilkd Source Type: research

More News: Eyes